Carbon-11-methionine PET in focal cortical dysplasia: a comparison with fluorine-18-FDG PET and technetium-99m-ECD SPECT. 1998

M Sasaki, and Y Kuwabara, and T Yoshida, and T Fukumura, and T Morioka, and S Nishio, and M Fukui, and K Masuda
Department of Radiology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Focal cortical dysplasia is one of the known neuronal migration disorders and has recently been recognized as a cause of intractable epilepsy. In this study, we assessed the 11C-methionine (MET) uptake in focal cortical dysplasia by PET, and then compared the results with that of 18F-fluoro-2-deoxy-D-glucose (FDG) PET and 99mTc-ethyl cysteinate dimer (ECD) SPECT. METHODS Four patients (3 men, 1 woman; age range 16-68 yr) were examined by PET and SPECT for a presurgical examination of medically intractable seizures. In all 4 patients, 11C-MET PET was performed for 15 min, started 15 min after the administration of 511-662 MBq MET. In 3 of 4 patients, FDG PET was performed for 15 min, and started 20 min after the administration of 185-370 MBq FDG. In all 4 patients, the cerebral blood flow was also evaluated by 99mTc-ECD SPECT for 15 min after the administration of 600 MBq ECD. RESULTS In MET PET, all 4 lesions were visually recognized to have high MET uptake areas. The MET uptake of the lesions was 1.44 +/- 0.30 for the standardized uptake value (SUV) (ranging from 0.99-1.61). In FDG PET, 2 lesions were demonstrated to have low uptake areas (3.82 in SUV) while 1 had an ictal high uptake (4.74 in SUV). In ECD SPECT, 1 lesion demonstrated hypoperfusion and 1 ictal hyperperfusion while 2 showed no abnormalities. All 4 patients underwent a cortical resection and the microscopic examinations were consistent with those of focal cortical dysplasia but no evidence of a tumor was found. CONCLUSIONS MET PET is useful for identifying focal cortical dysplasia as a high uptake area.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008715 Methionine A sulfur-containing essential L-amino acid that is important in many body functions. L-Methionine,Liquimeth,Methionine, L-Isomer,Pedameth,L-Isomer Methionine,Methionine, L Isomer
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

M Sasaki, and Y Kuwabara, and T Yoshida, and T Fukumura, and T Morioka, and S Nishio, and M Fukui, and K Masuda
September 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M Sasaki, and Y Kuwabara, and T Yoshida, and T Fukumura, and T Morioka, and S Nishio, and M Fukui, and K Masuda
February 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M Sasaki, and Y Kuwabara, and T Yoshida, and T Fukumura, and T Morioka, and S Nishio, and M Fukui, and K Masuda
July 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M Sasaki, and Y Kuwabara, and T Yoshida, and T Fukumura, and T Morioka, and S Nishio, and M Fukui, and K Masuda
April 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M Sasaki, and Y Kuwabara, and T Yoshida, and T Fukumura, and T Morioka, and S Nishio, and M Fukui, and K Masuda
April 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M Sasaki, and Y Kuwabara, and T Yoshida, and T Fukumura, and T Morioka, and S Nishio, and M Fukui, and K Masuda
December 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M Sasaki, and Y Kuwabara, and T Yoshida, and T Fukumura, and T Morioka, and S Nishio, and M Fukui, and K Masuda
April 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M Sasaki, and Y Kuwabara, and T Yoshida, and T Fukumura, and T Morioka, and S Nishio, and M Fukui, and K Masuda
April 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M Sasaki, and Y Kuwabara, and T Yoshida, and T Fukumura, and T Morioka, and S Nishio, and M Fukui, and K Masuda
November 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M Sasaki, and Y Kuwabara, and T Yoshida, and T Fukumura, and T Morioka, and S Nishio, and M Fukui, and K Masuda
February 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!